Quick Answer
IMMUNIC, INC. reported Stockholders Equity of -$6.67 million for fiscal year 2025.
IMMUNIC, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$6.67M | -136.2% |
| 2024 | $18.43M | -36.3% |
| 2023 | $28.93M | -74.6% |
| 2022 | $113.68M | -10.6% |
| 2021 | $127.11M | -19.9% |
| 2020 | $158.78M | +172.1% |
| 2019 | $58.36M | +326.7% |
| 2018 | -$25.74M | -93.0% |
| 2017 | -$13.34M | -122.8% |
| 2016 | $58.45M | -29.0% |
| 2015 | $82.33M | -15.6% |
| 2014 | $97.56M | +318.5% |
| 2013 | -$44.66M | -485.1% |
| 2012 | -$7.63M | +86.1% |
| 2011 | -$54.85M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $10.50M | -74.5% | -69.0% |
| June 30, 2025 | $33.91M | -46.7% | +741.4% |
| March 31, 2025 | -$5.29M | -106.3% | -128.7% |
| December 31, 2024 | $18.43M | -36.3% | -55.3% |
| September 30, 2024 | $41.22M | -14.8% | -35.2% |
| June 30, 2024 | $63.57M | -8.2% | -23.9% |
| March 31, 2024 | $83.58M | -8.4% | +188.9% |
| December 31, 2023 | $28.93M | -74.6% | -40.2% |
- IMMUNIC, INC. showed a decrease of -136.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2011–2025 period, IMMUNIC, INC.’s stockholders equity has grown by 87.8% (from -$54.85 million to -$6.67 million).
- The most recent figure is from IMMUNIC, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: